China In-Focus: China Medical Technologies Authorizes $30 Million Buyback
September 21, 2009, 2009 (FinancialWire) — China Medical Technologies, Inc. (NASDAQ: CMED) board has approved a share repurchase program authorizing the company to repurchase up to $30 million worth of its outstanding American depositary shares for a period of one year, starting on October 1.
The company plans to fund repurchases made under this program from its available cash balance.
Beijing-based China Medical Technologies is a medical device company that develops, manufactures and markets in-vitro diagnostic products to detect and monitor various diseases and disorders.
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).